Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Third Harmonic Bio, Inc. - Common Stock (NQ: THRD )

11.77 +0.32 (+2.75%)
Streaming Delayed Price Updated: 10:19 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,129
Open 11.60
Bid (Size) 11.49 (10)
Ask (Size) 11.90 (3)
Prev. Close 11.45
Today's Range 11.48 - 12.02
52wk Range 6.820 - 16.94
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire

Performance

YTD
+4.67%
+4.67%
1 Month
-12.14%
-12.14%
3 Month
-0.21%
-0.21%
6 Month
-15.78%
-15.78%
1 Year
+56.66%
+56.66%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
From Third Harmonic Bio
Via GlobeNewswire
Recap: Third Harmonic Bio Q4 Earnings
Via Benzinga
Third Harmonic Bio: Q3 Earnings Insights
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024
Via InvestorPlace
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q1 2024
Via InvestorPlace
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q4 2023
Via InvestorPlace
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Leadership Changes
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces First Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Top 5 Health Care Stocks That May Rally
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.